HOME >> BIOLOGY >> NEWS
Taxpayer Alliance applauds congressional mandate for NIH public access

Washington, DC June 15, 2006 The Alliance for Taxpayer Access (ATA) strongly supports the U.S. House Appropriations Committee's provision directing the National Institutes of Health (NIH) to require its research grantees to submit an electronic version of their final, peer-reviewed manuscript to the National Library of Medicine's PubMed Central online archive upon acceptance for publication in a journal.

The House Appropriations Committee took this official step, which strengthens the public access policy undertaken by NIH a year ago, as they approved the FY 2007 Labor, HHS, Education, and Related Agencies appropriations measure. The NIH policy, currently voluntary, has resulted in researchers' deposit of less than five percent of available NIH-funded research. The House Appropriations bill with the new directive will now be considered by the U.S. House of Representatives. The U.S. Senate will consider its Labor, HHS, Education, and Related Agencies Appropriations bill sometime this summer.

"This action is a clear signal from Congressional leaders that they are committed to advancing the cause of science and the public interest," said Heather Joseph, Executive Director of SPARC (the Scholarly Publishing and Academic Resources Coalition, an ATA founding member). "The bill is a significant step in acknowledging the profound impact the Internet has on the conduct of scientific research and the need for this research to be shared as widely as possible."

The bill also stipulates a maximum 12-month window for authors to submit their peer-reviewed manuscripts. The ATA believes this lengthy timeframe will delay important research advances and the dissemination of information to stakeholders who rely on it. "We applaud the House Appropriations Committee for taking this tremendous stride forward," said Pat Furlong, Founding President & CEO of Parent Project Muscular Dystrophy. "For individuals and families struggling to stay abreast of scientific dev
'"/>

Contact: Jennifer Heffelfinger
jennifer@arl.org
202-247-6185
SPARC
15-Jun-2006


Page: 1 2

Related biology news :

1. Taxpayer Alliance supports senate bill broadening access to federal research
2. Taxpayer advocacy group says Cures Bill is the right medicine
3. BG Group and Conservation International launch Conservation through Photography Alliance
4. Colon Cancer Alliance launches interactive support program
5. Wildlife Conservation Society joins Climate, Community & Biodiversity Alliance
6. TB Alliance and Bayer launch historic global drug trials for tuberculosis
7. Conservation International and AF&PA join forces to form Alliance to Combat Illegal Logging
8. Dietary Guidelines Alliance offers tools to help consumers understand new nutrition guidance
9. JDRF applauds important passage of the Stem Cell Research Enhancement Act of 2007
10. AAAS applauds nationwide science and math standards based on existing guidelines
11. BioMed Central applauds Wellcomes leadership on Open Access

Post Your Comments:
(Date:5/14/2015)... May 14, 2015  Verificient Technologies, Inc., ... and online remote proctoring, announced a new ... company and creator of the Canvas Learning ... two companies will benefit from the seamless ... As a fully integrated multifactor biometrics ...
(Date:5/11/2015)... Ohio , May 11, 2015  Through a well-rounded ... Ohio had a strong showing at AUVSI,s Unmanned ... These representatives of Ohio,s UAS industry ... and abroad from all points along the UAS ecosystem. ... Development Coalition,s (DDC) Vice President for Aerospace Rich Knoll ...
(Date:5/10/2015)... GOTHENBURG, Sweden , May 11, 2015 ... touch fingerprint sensors FPC1025 and FPC1155 from the distributor World ... one of FPC,s distributors in Asia . ... the sensors will be used by smartphone manufacturers in ... is included in the communicated revenue guidance of + 1 000 ...
Breaking Biology News(10 mins):Verificient and Instructure Announce Alliance Partnership to Provide Online Proctoring for K-12 and Higher Education Institutions 2Ohio Flies High at Unmanned '15, Sets Stage for Ohio UAS Conference 2Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 235 Million 2
(Date:5/21/2015)... Specialty Pharmacy Times has completed its ... BPA Worldwide as a business publication member. As ... for Specialty Pharmacy Times based on business/distribution, demographics ... member of BPA Worldwide, Specialty Pharmacy Times shows ... the most reliable, unequaled data,” said Chris Hennessy, ...
(Date:5/21/2015)... 21, 2015  The EveryLife Foundation for Rare ... and Amy Klobuchar (D-MN) today for ... & Treatments, or OPEN ACT. Supported ... organizations, this bipartisan legislation promises to rapidly bring ... rare disease patients by incentivizing drug makers to ...
(Date:5/21/2015)... , May 21, 2015  CytRx Corporation (NASDAQ: ... company specializing in oncology, today announced positive updated ... with aldoxorubicin for the treatment of unresectable glioblastoma ...  The open-label, multisite trial is designed to investigate ... patients whose tumors have progressed following prior treatment ...
(Date:5/21/2015)... Veolia’s environmental monitoring technology division, ... distribution agreement with VWR to distribute TECTA™ B16, ... than 160 years of experience, VWR, a leading ... and production facilities, has cultivated a value proposition ... to enable science. Endetec’s TECTA™ B16, combines ...
Breaking Biology Technology:Specialty Pharmacy Times Joins BPA Worldwide 2Advocates Cheer Senate Leaders for Introducing Bipartisan Bill to Increase Number of Rare Disease Treatments 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7Veolia’s TECTA™ B16 Instrument for E. Coli Detection is Offered Exclusively Through VWR 2
Cached News: